carmofur has been researched along with epirubicin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, T; Kohno, H; Nagasue, N; Ono, T; Uchida, M; Yamanoi, A; Yukaya, H | 1 |
Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS | 1 |
Kohno, H; Nagasue, N; Nazmy El Assal, O; Ono, T; Yamanoi, A | 1 |
1 review(s) available for carmofur and epirubicin
Article | Year |
---|---|
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tegafur; Treatment Outcome | 2001 |
1 trial(s) available for carmofur and epirubicin
Article | Year |
---|---|
Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate | 1997 |
1 other study(ies) available for carmofur and epirubicin
Article | Year |
---|---|
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Brain; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nervous System Diseases; Prednisolone; Radiography | 2001 |